Polysubstance Abuse in the Critically Ill: The Multitude of Challenges and Care Considerations

Author(s): Pamela J Bolton, PhD,MS,ACNPC,CCNS,CCRN,PCCN,RN,FAANP

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 0.50

Expires Dec 31, 2028

Topics: Pharmacology, Behavioral/Psychosocial

Population: Adult

Role: APRN, Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Before you Begin

1. Reflect on the following question: What new knowledge or perspective do you hope to gain from this activity?

2. Review: Implicit Bias and its Impact on Patient Outcomes (License requirement for California)

Description

Polysubstance abuse disorder (SUD) is a significant issue throughout the world, but especially in the United States. SUD serves as a major risk factor for higher-acuity illness and is associated with poor outcomes. Especially difficult is managing patients' pain, anxiety and potential withdrawal. This session provides advanced content on the impact of SUD on critical illness. Common substance combinations are explored along with the pathophysiologic effects of these substances. Issues with assessment, management (including airway, hemodynamic stabilization, agitation/delirium, and antidotes) are discussed. Ethical and post-ICU considerations are reviewed in the session. Pharmacology content = 50%

Objectives

  • Define polysubstance abuse by identifying substance combinations commonly presented in critical care.
  • Describe the pathophysiological effects of polysubstance abuse in critically ill patients.
  • Analyze the toxidrome findings and the impact on diagnostic and critical care-related challenges.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.